Total income more than doubled to ₹1,540.99 crore during the January-March period of 2025-26 from ₹563.70 crore in the corresponding period of the preceding year
Q4FY26 company results: Firms including Zydus Lifesciences, BASF India, PI Industries, Zee Entertainment, and Bosch Home Comfort India are also to release their January-March earnings today
IGL's revenue from operations rose 5.6% YoY in the quarter to ₹4,584.58 crore
Strong growth in non-US markets lifted Strides Pharma Science's Q4 profit, even as its US business remained largely flat amid a weak flu season
The company had posted a net profit of ₹171.9 crore for the year-ago period, Zydus Wellness said in a regulatory filing
Q4FY26 company results: Firms including Astral, Triveni Turbine, Strides Pharma, DOMS Industries, Strides Pharma Science, and JK Paper are also to release their January-March earnings today
Total income of the company for the quarter under review stood at ₹2,909 crore, up 26.31 per cent year-on-year from ₹2,303 crore in Q4FY25, the company said
The company had delivered a bottomline of ₹266-crore in the quarter ended March 2025
Aditya Birla group to infuse Rs 4,730 crore from Singapore-based promoter entity
The consolidated net profit was ₹4,142.87 crore in the quarter ended on March 31, 2025, a regulatory filing showed
The company had posted a loss of ₹7,167 crore in the same period a year ago
Q4FY26 company results: Firms including UNO Minda, Genus Power Infrastructures, Neogen Chemicals, Tatva Chintan Pharma Chem, and Rolex Rings are also to release their January-March earnings today
Consolidated total revenue from operations in Q4FY26 stood at Rs 3,485.54 crore as against Rs 1,887.79 crore in the year-ago period
Tata Steel posted a sharp rise in fourth-quarter profit, supported by stronger India deliveries, improved product mix and cost transformation across regions
The company had posted a net profit of Rs 59.05 crore in January-March FY25, according to a regulatory filing from Bajaj Electricals
Welspun Living's FY26 earnings were hit by tariff and geopolitical disruptions, though the company expects recovery momentum to continue into FY27
Alembic Pharmaceuticals posted strong fourth-quarter profit growth, aided by revenue gains across segments and its entry into the US branded market
The company had posted a consolidated net profit of Rs 187.18 crore in the year-ago period
The company's revenue from operations increased 13% to ₹63,270 crore in Q4FY26 from ₹56,218 crore in Q4FY25
In the same quarter last year, ITC Hotels had posted a net profit of ₹257.85 crore